[Efficacy and safety of low-dose levonorgestrel-releasing intrauterine system in Chinese women: a multicenter, single-arm, open labeled interventional trial].

Objective: To evaluate the efficacy, bleeding profile and safety of low-dose levonorgestrel-releasing intrauterine system (LNG-IUS 8) in Chinese healthy women of childbearing age. Methods: A multi-center, open-label, single-arm clinical trial conducted at 16 centres in China enrolled 773 healthy women of childbearing age (mean age 31.6 years old, range 18 to 40 years old) , who demanded contraception, from April 2006 to June 2013. All women placed LNG-IUS 8 for 3 years and then been followed up at 3, 6, 9, 12, 18, 24, 30, 36 months. The efficacy variables including pregnancy rate and expulsion rate were analyzed using life table, while observing adverse events (AE) to evaluate the safety. The bleeding profile happened during the study was assessed using 90-day reference intervals (World Health Organization criteria) . Results: Eight pregnancies occurred among 773 women, resulting in a overall Pearl index of 0.42 per 100 women years. The 3-year cumulative pregnancy rate was 0.37 per 100 women years and the 3-year cumulative expulsion rate was 1.99 per 100 women years. The number of women with bleeding/spotting reduced and the bleeding/spotting days declined over time. Totally 219 AE were reported related to LNG-IUS 8 placements. The most common AE were vaginal bleeding (8.2%, 63/773) and the ovarian cyst (6.2%, 52/773) . LNG-IUS 8 had an improving effect on dysmenorrhea that the percentage of women with dysmenorrhea as well as the days of dysmenorrhea decreased over time. The percentage of women satisfied or very satisfied with LNG-IUS 8 was 87.2% (622/713) . Conclusion: LNG-IUS 8 is highly effective and safe for Chinese healthy women of childbearing age.

Breeding of new Rehmannia glutinosa variety.

Huaidi 81, a new variety of Rehmannia glutinosa with excellent comprehensive characters, was screened by space mutation of hybrid seeds of 85-5 and Beijing No.1. The fresh weight, index composition, resistance, chlorophyll, anthocyanin and photosynthetic characteristics of Huaidi 81 and the main cultivars were determined. The results showed that: the per plant fresh weight of Rehmannia ranked in the order as follows: Huaidi 81 > 85-5 > Golden Nine >Huaifeng >Qinhuai>Beijing No.3, there was extremely significant difference between Huaidi 81 and others. The catalpol content ranked in the following order: Beijing No.3 (1.601%)> Qinhuai (1.588%)> Huaidi 81 (1.314%)> Golden Nine > 85-5 (1.073%)> Huaifeng (0.924%). There was no significant difference between Huaidi 81 and Golden Nine, but extremely significant difference between was found in Huaidi 81 and other varieties; The acteoside content ranked in the following following order: Huaidi 81 (0.096%) > Qin Huai (0.069%) >85-5 (0.047%) > Beijing No.3 (0.035%) > Huaifeng (0.023%) > Golden Nine (0.022%). There was significant difference between Huaidi 81 and other varieties. Huaidi 81 showed high resistance to Septoris digitalis Pass and middle resistance against leaf ring rot, which indicated that Huaidi 81 had good resistance to leaf diseases. Huaidi 81 with highest chlorophyll content and moderate anthocyanin content showed the highest photosynthetic rate. All these results indicated that the new variety Huaidi 81 with best comprehensive properties was suitable for popularizing as a new Rehmannia glutinosa variety.

Environmental exposure and risk of uterine leiomyoma: an epidemiologic survey.

AIM: The present study was undertaken to explore the relationship between environmental exposure and risk of uterine leiomyoma in women using an epidemiologic survey. SUBJECTS AND METHODS: We conducted a case-control survey of premenopausal Han women aged 30-50 years in Nanjing. The subjects included 600 patients with uterine leiomyoma confirmed at the Affiliated Zhongda Hospital of Southeast University between February 2010 and June 2012 and 600 patients with non-uterine leiomyoma or healthy volunteers who presented to the above mentioned hospital for physical examination during the same period. We entered the results into a database and explored the relationship between risk factors and prevalence of uterine leiomyoma using univariate or multivariate non-conditional logistic regression analysis. RESULTS: The results showed that patients aged 40-45 years had a high prevalence of uterine leiomyoma. The prevalence of uterine leiomyoma in subjects with an education beyond high school was higher than in those with a high school education or less. Exposure to plastic products (odds ratio [OR]: 1.481; 95% confidence interval [CI]: 1.046-2.097); exposure to cosmetics and other chemicals (OR: 1.954; 95% CI: 1.479-2.582); and consumption of soybean milk (OR: 2.518; 95% CI: 1.894-3.347), food additives, sweeteners, and preserved food (OR: 3.166, 95% CI: 2.247-4.461) had a significant effect on the occurrence of uterine leiomyoma (p < 0.05). CONCLUSIONS: Exposure to plastic products, cosmetics, and other chemicals as well as intake of soybean milk, food additives, sweetener, and preserved foods may be risk factors for uterine leiomyoma.

Octreotide is the favorable alternative for cisplatin resistance reversal of ovarian cancer in vitro and in nude mice in vivo.

This study aimed to observe the effects of octreotide (OCT) on cisplatin resistance reversal of cancer cells in vitro and in nude mice in vivo. MTT method and flow cytometry were used to investigate the effect of cisplatin, OCT or the combination of these two compounds on the proliferation and apoptosis of SKOV3-DDP cells. The size and weight of xenograft tumors from the nude mice model were measured. Real-time PCR was used to detect the mRNA expression of SSTR2, MDR1, MRP2, GST-pi and EGFR in SKOV3/DDP cells following the different treatment. At the concentration of 2.5-20 g/ml, OCT significantly reduced IC50 (p < 0.05) and promoted apoptosis (p < 0.05) of SKOV3-DDP cells' response to cisplatin. Unchanged expression was found in SSTR2 on the SKOV3/DDP cell in vitro after OCT treatment, but increased expression in vivo (p < 0.05). OCT increased GST-pi expression (p < 0.05) and reduced MRP2 and EGFR expression (p < 0.05) in a dose-dependent manner. The similar results were obtained in mice in vivo experiment, except the reduced expression of GST-pi. It is suggested that OCT could inhibit ovarian cancer proliferation and promote apoptosis, via the cell surface SSTR2, and reverse cisplatin resistance through inhibition of MRP2, EGFR, and even GST-pi expressions.